A First in Human Study of the Menin-KMT2A (MLL1) Inhibitor JNJ-75276617 in Participants with Acute Leukemia

ENROLLING
Protocol # :
21-355
Phase
I
Disease Sites
Myeloid and Monocytic Leukemia
Principal Investigator
Stone, Richard, M
Site Research Nurses
Ramos, Aura
Ruiz, Sara
Som, Tina
Vartanian, Megan
White, Laura

Trial Description

Call 877-DF-TRIAL (877-338-7425) to learn more about this clinical trial, protocol #21-355

21-355